Cost Effectiveness of Onabotulinumtoxina Versus Ptns and Sns for the Treatment of Overactive Bladder from the US Payer Perspective

May 1, 2016, 00:00
10.1016/j.jval.2016.03.534
https://www.valueinhealthjournal.com/article/S1098-3015(16)00602-1/fulltext
Title : Cost Effectiveness of Onabotulinumtoxina Versus Ptns and Sns for the Treatment of Overactive Bladder from the US Payer Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00602-1&doi=10.1016/j.jval.2016.03.534
First page : A130
Section Title : Urinary/Kidney Disorders - Cost Studies
Open access? : No
Section Order : 192
Categories :
Tags :
Regions :
ViH Article Tags :